close

Enter

Log in using OpenID

Aneurysm Treatment Market Global Trends, Market Share, Industry Size, Growth, Opportunities, and Market Forecast 2019 to 2026

embed
Global aneurysm treatment market foreseen to grow over a CAGR of 5% during 2019-2026.
Aneurysm Treatment Market Global Trends, Market Share, Industry Size, Growth,
Opportunities, and Market Forecast 2019 to 2026
Global aneurysm treatment market foreseen to grow over a CAGR of
5% during 2019-2026.
Aneurysm is the expansion of artery which is caused by weakness in the arterial wall.
It appears in the areas where large arteries branch into smaller ones and it's
observed at the base of the brain. Aneurysm can result in brain damage or stroke
and has the potential to rupture which causes bleeding in the neighboring subarachnoid space. According to CDC, aneurysm contributes annually more than 25,000
deaths in the US. An estimated 40% of these cases can cause death in less than 24
hours. Aneurysm demand immediate medical attention and has a huge demand in
primary healthcare settings. The healthcare systems are more focused on preventive
techniques to control the incidence. The ascending occurrences of high blood
pressure and the fast advancements of surgical techniques remain the key drivers of
the market. The government and other healthcare sectors are providing funds, which
further indicates the potential growth of Aneurysm treatment market. All these
factors hint towards the potential growth of the market during the forecast period.
Impelling growth of the global aneurysm treatment market can be attributed to a
number of dynamics including:
• Incremental prevalence of brain aneurysms
• Improvement in surgical techniques
• The escalating occurrence of high blood pressure
• Rising healthcare funding by government bodies
• Presence of brain aneurysm in the family history
• The manifestation of familial aneurysms among subarachnoid haemorrhage
patients
• Increasing trauma and blood infection incidences
Request a Sample Report @ https://www.futurewiseresearch.com/requestsample.aspx?id=179&page=requestsample
Aneurysm Treatment Market Restraints
• Expensive management cost of aneurysmal subarachnoid hemorrhage
• Undisclosed symptoms of unruptured brain aneurysm
The global Aneurysm treatment market is projected to reach a significant market
value in terms of revenue by the end of 2026, registering a robust CAGR of
over 5% during 2019-2026. Despite the aforementioned drivers and healthy
projections, there are certain concerns associated with brain aneurysm treatment
that are prospective to hinder the growth of the global aneurysm treatment market.
These concerns include:
• Unidentified symptoms of an unruptured brain aneurysm
• High cost associated with aneurysmal subarachnoid haemorrhage management
Global Aneurysm Treatment Market by Product Type
+ Surgical Clipping
+ Endovascular Coiling
+ Flow diverters
Surgical clipping is widely used effective treatment for brain aneurysms patients.
Small metallic clip or clips are placed along the neck of the aneurysm to reduce the
risk of bleeding by preventing blood from entering into the aneurysm sac. The clip
remains in place for a lifetime while aneurysm shrinks and scar down permanently
with an exceptionally low risk of redeveloping. Hence the surgical clipping segment is
projected to grow at a rapid pace during the forthcoming period.
Global Aneurysm Treatment Market by End User
+ Hospitals
+ Neurological Centres
Global Aneurysm Treatment Market by Region
+ North America
+ Latin America
+ Europe
+ Asia Pacific
+ Rest of the World
North America currently holds the dominant market share and the expected
significant growth in the forthcoming years is attributed to the increasing
occurrences of a brain aneurysm. The European region holds the subsequent leading
share of the global aneurysm treatment market. Prevalent cerebrovascular
conditions, government-backed research and development along with improved
medical reimbursement policies in the region are proliferating healthy growth
herein. The Asia Pacific region is positioned as the potentially fastest growing region
and significant the key player in the global aneurysm treatment terrain, owing to
upgrading healthcare technology and a massive patient population.
The Rest of the world region holds moderate growth potential and a minimal share in
the global aneurysm treatment market owing to the lack of proper disposal of
remedial services. However, the decent growth in this region is driven by some of the
most advancing countries like UAE, Saudi Arabia and Kuwait in the Middle East.
Purchase a Copy & Ask For Discount:
https://www.futurewiseresearch.com/requestsample.aspx?id=179&page=askfordiscount
Competitive Landscape
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants
FutureWise Key Takeaways
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth
Objectives of the Study:
• To provide with an exhaustive analysis on the global aneurysm treatment market
by product type, by end user, and by region
• To cater comprehensive information on factors impacting market growth (drivers,
restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions (along with countries)—North America,
Europe, Asia Pacific, Latin America, and the Middle East
• To record evaluate and competitive landscape mapping- product launches,
technological advancements, mergers and expansions
• Profiling of companies to evaluate their market shares, strategies, financials and
core competencies.
Table of Contents
1.1. Introduction
1.1.1.1. Scope and Objective
1.1.1.2. Assumptions and Acronyms
1.1.1.3. Forecast Factors
1.1.1.4. Research Methodology
1.2. Executive Summary
1.2.1.1. Industry Cluster Analysis
1.2.1.2. Competition Matrix
1.2.1.3. Strategies Recommendations
1.3. Market Definition
1.3.1.1. Report Scope (Inclusions & Exclusions)
1.3.1.2. Market Segmentation
1.4. Global Aneurysm Treatment Market Overview
1.4.1.1. Global Aneurysm Treatment Market Revenue (USD Mn)
1.5. Key Inclusions
1.5.1.1. Porter’s Five Force analysis
1.5.1.2. Market Dynamics
1.5.1.3. Industry Trends
1.5.1.4. Regulatory Guidelines
1.5.1.5. Opportunities in Aneurysm Treatment
1.6. Competition Dynamics
1.6.1.1. Company Share Analysis (2018)
1.6.1.2. Top 10 Product Pricing by Region
1.7. Global Aneurysm Treatment Market Revenue (USD Mn), 2018-2026 by
Product Type
1.7.1.1. Key Market Findings
1.7.1.2. Long Term ROI Segments
1.7.1.3. Revenue Opportunity Influencing Factors
1.7.1.4. Market Revenue (USD Mn) Assessment and Forecast by Product
Type, 2018-2026
1.7.1.4.1.1.
Surgical Clipping
1.7.1.4.1.2.
Endovascular Coiling
1.7.1.4.1.3.
Flow diverters
1.8. Global Aneurysm Treatment Market Revenue (USD Mn), 2018-2026 by End
User
1.8.1.1. Key Market Findings
1.8.1.2. Long Term ROI Segments
1.8.1.3. Revenue Opportunity Influencing Factors
1.8.1.4. Market Revenue (USD Mn) Assessment and Forecast by End
User, 2018-2026
1.8.1.4.1.1.
Hospitals
1.8.1.4.1.2.
Neurological Centres
1.9. Global Aneurysm Treatment Market Revenue (USD Mn), 2018-2026 by
Region
1.9.1.1. Key Market Findings
1.9.1.2. Long Term ROI Segments
1.9.1.3. Revenue Opportunity Influencing Factors
1.9.1.4. Market Revenue (USD Mn) Assessment and Forecast by
Region,2026
1.9.1.4.1.1.
North America
1.9.1.4.1.2.
Latin America
1.9.1.4.1.3.
Europe
1.9.1.4.1.4.
Asia Pacific
1.9.1.4.1.5.
Rest of world
1.10.
North America Aneurysm Treatment Market Revenue (US$ Mn),
2018-2026
1.10.1.1. Key Market Findings
1.10.1.2. Long Term ROI Segments
1.10.1.3. Revenue Opportunity Influencing Factors
1.10.1.4. Market Revenue (USD Mn) Assessment and Forecast by Country,
2018-2026
1.10.1.4.1.1.
US
1.10.1.4.1.2.
Canada
1.10.1.5. Market Revenue (USD Mn) Assessment and Forecast by Product
Type, 2018-2026
1.10.1.5.1.1.
Surgical Clipping
1.10.1.5.1.2.
Endovascular Coiling
1.10.1.5.1.3.
Flow diverters
1.10.1.6. Market Revenue (USD Mn) Assessment and Forecast by End
User, 2018-2026
1.10.1.6.1.1.
Hospitals
1.10.1.6.1.2.
Neurological Centres
1.11.
Latin America Aneurysm Treatment Market Revenue (US$ Mn), 20182026
1.11.1.1. Key Market Findings
1.11.1.2. Long Term ROI Segments
1.11.1.3. Revenue Opportunity Influencing Factors
1.11.1.4. Market Revenue (USD Mn) Assessment and Forecast by Country,
2018-2026
1.11.1.4.1.1.
Brazil
1.11.1.4.1.2.
Mexico
1.11.1.4.1.3.
Argentina
1.11.1.4.1.4.
Rest of Latin America
1.11.1.5. Market Revenue (USD Mn) Assessment and Forecast by Product
Type, 2018-2026
1.11.1.5.1.1.
Surgical Clipping
1.11.1.5.1.2.
Endovascular Coiling
1.11.1.5.1.3.
Flow diverters
1.11.1.6. Market Revenue (USD Mn) Assessment and Forecast by End
User, 2018-2026
1.11.1.6.1.1.
Hospitals
1.11.1.6.1.2.
Neurological Centres
1.12.
Europe America Aneurysm Treatment Market Revenue (US$ Mn),
2018-2026
1.12.1.1. Key Market Findings
1.12.1.2. Long Term ROI Segments
1.12.1.3. Revenue Opportunity Influencing Factors
1.12.1.4. Market Revenue (USD Mn) Assessment and Forecast by Country,
2018-2026
1.12.1.4.1.1.
Germany
1.12.1.4.1.2.
France
1.12.1.4.1.3.
Spain
1.12.1.4.1.4.
UK
1.12.1.4.1.5.
Russia
1.12.1.4.1.6.
Poland
1.12.1.4.1.7.
Rest of Europe
1.12.1.5. Market Revenue (USD Mn) Assessment and Forecast by Product
Type, 2018-2026
1.12.1.5.1.1.
Surgical Clipping
1.12.1.5.1.2.
Endovascular Coiling
1.12.1.5.1.3.
Flow diverters
1.12.1.6. Market Revenue (USD Mn) Assessment and Forecast by End
User, 2018-2026
1.12.1.6.1.1.
Hospitals
1.12.1.6.1.2.
Neurological Centres
1.13.
Asia Pacific America Aneurysm Treatment Market Revenue (US$ Mn),
2018-2026
1.13.1.1. Key Market Findings
1.13.1.2. Long Term ROI Segments
1.13.1.3. Revenue Opportunity Influencing Factors
1.13.1.4. Market Revenue (USD Mn) Assessment and Forecast by Country,
2018-2026
1.13.1.4.1.1.
Emerging Asia
1.13.1.4.1.1.1.1. China
1.13.1.4.1.1.1.2. India
1.13.1.4.1.1.1.3. ASEAN-5
1.13.1.4.1.1.1.4. Rest of Emerging Asia
1.13.1.4.1.2.
Japan
1.13.1.5. Market Revenue (USD Mn) Assessment and Forecast by Product
Type, 2018-2026
1.13.1.5.1.1.
Surgical Clipping
1.13.1.5.1.2.
Endovascular Coiling
1.13.1.5.1.3.
Flow diverters
1.13.1.6. Market Revenue (USD Mn) Assessment and Forecast by End
User, 2018-2026
1.13.1.6.1.1.
Hospitals
1.13.1.6.1.2.
Neurological Centres
1.14.
Rest of World America Aneurysm Treatment Market Revenue (US$
Mn), 2018-2026
1.14.1.1. Key Market Findings
1.14.1.2. Long Term ROI Segments
1.14.1.3. Revenue Opportunity Influencing Factors
1.14.1.4. Market Revenue (USD Mn) Assessment and Forecast by Country,
2018-2026
1.14.1.4.1.1.
Middle East
1.14.1.4.1.2.
South Africa
1.14.1.4.1.3.
North Africa
1.14.1.4.1.4.
Rest of World
1.14.1.5. Market Revenue (USD Mn) Assessment and Forecast by Product
Type, 2018-2026
1.14.1.5.1.1.
Surgical Clipping
1.14.1.5.1.2.
Endovascular Coiling
1.14.1.5.1.3.
Flow diverters
1.14.1.6. Market Revenue (USD Mn) Assessment and Forecast by End
User, 2018-2026
1.14.1.6.1.1.
Hospitals
1.14.1.6.1.2.
Neurological Centres
1.15.
Company Profiles
1.15.1.1. Competition Landscape
1.15.1.2. Global Company Share (USD Mn) Overview, 2018
1.15.1.3. Company Profiles
1.15.1.3.1.1.
Penumbra
1.15.1.3.1.1.1.1. Corporate Overview
1.15.1.3.1.1.1.2. Financial Performance
1.15.1.3.1.1.1.3. Peer Comparison & 3C marketing equation
1.15.1.3.1.1.1.4. Company Strategy & Channel Management
1.15.1.3.1.2.
Terumo Medical Incorporated
1.15.1.3.1.2.1.1. Corporate Overview
1.15.1.3.1.2.1.2. Financial Performance
1.15.1.3.1.2.1.3. Peer Comparison & 3C marketing equation
1.15.1.3.1.2.1.4. Company Strategy & Channel Management
1.15.1.3.1.3.
Medtronic Plc
1.15.1.3.1.3.1.1. Corporate Overview
1.15.1.3.1.3.1.2. Financial Performance
1.15.1.3.1.3.1.3. Peer Comparison & 3C marketing equation
1.15.1.3.1.3.1.4. Company Strategy & Channel Management
1.15.1.3.1.4.
phenox GmbH
1.15.1.3.1.4.1.1. Corporate Overview
1.15.1.3.1.4.1.2. Financial Performance
1.15.1.3.1.4.1.3. Peer Comparison & 3C marketing equation
1.15.1.3.1.4.1.4. Company Strategy & Channel Management
1.15.1.3.1.5.
B. Braun Melsungen AG
1.15.1.3.1.5.1.1. Corporate Overview
1.15.1.3.1.5.1.2. Financial Performance
1.15.1.3.1.5.1.3. Peer Comparison & 3C marketing equation
1.15.1.3.1.5.1.4. Company Strategy & Channel Management
1.15.1.3.1.6.
Stryker Corporation
1.16.
1.15.1.3.1.6.1.1. Corporate Overview
1.15.1.3.1.6.1.2. Financial Performance
1.15.1.3.1.6.1.3. Peer Comparison & 3C marketing equation
1.15.1.3.1.6.1.4. Company Strategy & Channel Management
Research Sources & Primary Verbatim
Inquire further details about this report at: [email protected]
About FutureWise Research:
We specialise in high-growth niche markets, assuring flexibility, agility and
customised solutions for our clients. Through in-depth market insights and
consultancy, we present our clients with the tools they need to be at the forefront of
their industry – a position secured for far more than the near future.
Contact Us:
Company Name: FutureWise Research
Contact Person: Vinay Thaploo
Email: [email protected]
Phone: +44 141 628 9353 / +1 970 279 4295
City: Leeds
Country: United Kingdom
Website: www.futurewiseresearch.com
Author
Merin John
Merin John263   documents Email
Document
Category
Health and Medicine
Views
2
File Size
21 KB
Tags
treatment
1/--pages
Report inappropriate content